KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to 25.75%.

  • Petmed Express' EBITDA Margin fell 248800.0% to 25.75% in Q4 2025 from the same period last year, while for Dec 2025 it was 31.56%, marking a year-over-year decrease of 318300.0%. This contributed to the annual value of 1.57% for FY2025, which is 26900.0% up from last year.
  • Latest data reveals that Petmed Express reported EBITDA Margin of 25.75% as of Q4 2025, which was down 248800.0% from 18.89% recorded in Q3 2025.
  • Petmed Express' 5-year EBITDA Margin high stood at 13.09% for Q3 2021, and its period low was 66.69% during Q2 2025.
  • For the 5-year period, Petmed Express' EBITDA Margin averaged around 2.86%, with its median value being 1.11% (2023).
  • As far as peak fluctuations go, Petmed Express' EBITDA Margin soared by 72200bps in 2024, and later crashed by -733100bps in 2025.
  • Quarter analysis of 5 years shows Petmed Express' EBITDA Margin stood at 9.67% in 2021, then tumbled by -97bps to 0.3% in 2022, then crashed by -1707bps to 4.83% in 2023, then soared by 82bps to 0.87% in 2024, then tumbled by -2873bps to 25.75% in 2025.
  • Its EBITDA Margin was 25.75% in Q4 2025, compared to 18.89% in Q3 2025 and 66.69% in Q2 2025.